Poloxamer 188 & POLOXAMER 188 Excipient Use in For Suspension Extended Release Dosage Forms

Poloxamer 188

FDA Inactive Ingredient Details, DESCRIPTION

Suppliers

4 Listed Products, 1 Nanjing Bold Chemical, 1 Nanjing Well Pharmaceutical, 2 BASF

REGULATORY FILINGS

2 Suppliers, 1 USDMF, 1 JDMF

SOLUTIONS BY APPLICATIONS

2 Granulation, 2 Solubilizers, 2 Thickeners and Stabilizers, 1 Parenteral, 1 Direct Compression, 1 Topical, 1 Lubricants & Glidants

FINISHED FORMULATIONS

73 ORAL, 37 TABLET, 7 SUSPENSION, 6 FOR SOLUTION, 6 TABLET, EXTENDED RELEASE, 4 INJECTABLE, 4 INJECTION, 4 SOLUTION, 3 CAPSULE, 3 CAPSULE, DELAYED REL PELLETS, 3 FOR SUSPENSION, 3 GRANULE, 2 SUBCUTANEOUS, 2 TABLET, DELAYED RELEASE, 1 CREAM, 1 FOR SUSPENSION, EXTENDED RELEASE, 1 INTRAMUSCULAR, 1 OPHTHALMIC, 1 SOLUTION/DROPS, 1 TABLET, CHEWABLE, 1 TOPICAL